Timing of Myelosuppression During Thiopurine Therapy for Inflammatory Bowel Disease: Implications…

Dr. James D. Lewis discusses his manuscript Timing of Myelosuppression During Thiopurine Therapy for Inflammatory Bowel Disease: Implications for Monitoring Recommendations. To view the print version of this abstract go to ow.ly

Similar Posts:

• Timing of Myelosuppression During Thiopurine Therapy for Inflammatory Bowel Disease: Implications…
• Interactions Between the Host Innate Immune System and Microbes in…
• Environmental Triggers of Inflammatory Bowel Disease
• Breakthroughs in IBD Research: Helping You Today
• Inflammatory Bowel Disease

Tagged with: colitis • crohns • disease • epidemiology. • pharmacoepidemiology; • Ulcerative

Filed under: Inflammatory Bowel Disease

Like this post? Subscribe to my RSS feed and get loads more!

Possibly related posts